Industry in dispute with DoE over biotechnology regulation

Biotechnology businesses have continued their campaign for a relaxation of the EC rules governing the production and deliberate release of genetically manipulated organisms (GMOs) before an inquiry in the House of Lords. The industry maintains that the technology poses risks no higher than those of any other. But the Department of the Environment (DoE) and environmentalists have told the inquiry that regulation should err on the side of caution while commercialisation of GMOs is still in its infancy.

Sorry you do not have access to this article. Please contact Customer Support at
or call 020 8267 8120

The ENDS Report - subscribe today